No abstract available
MeSH terms
-
Acetamides / therapeutic use
-
Adult
-
Age Factors
-
Amantadine / therapeutic use
-
Antiviral Agents / therapeutic use
-
Child
-
Cost-Benefit Analysis
-
Creatine / urine
-
Disease Outbreaks / economics
-
Disease Outbreaks / prevention & control
-
Drug Resistance, Viral
-
Guanidines
-
Humans
-
Influenza A virus
-
Influenza, Human / complications
-
Influenza, Human / economics
-
Influenza, Human / therapy*
-
Influenza, Human / virology
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / metabolism
-
Metabolic Clearance Rate
-
Oseltamivir
-
Patient Selection
-
Primary Prevention / economics
-
Primary Prevention / methods
-
Pyrans
-
Sialic Acids / therapeutic use
-
Treatment Outcome
-
Zanamivir
Substances
-
Acetamides
-
Antiviral Agents
-
Guanidines
-
Pyrans
-
Sialic Acids
-
Oseltamivir
-
Amantadine
-
Zanamivir
-
Creatine